China Pharma Holdings (CPHI) Current Assets (2010 - 2026)

China Pharma Holdings has reported Current Assets for 17 years, with the latest figure at $2.0 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 29.72% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (down 29.72% YoY), and the FY2025 full-year result was $2.3 million, down 28.25% from the prior year.
• Current Assets for Q1 2026 stood at $2.0 million, down from $2.3 million in the prior quarter.
• The five-year high for Current Assets was $8.2 million in Q1 2022, with the low at $2.0 million in Q1 2026.
• Historically, Current Assets has averaged $4.6 million across 5 years, with a median of $5.1 million in 2024.
• Annual changes were most pronounced in 2022 — Current Assets jumped 67.22% — and 2024, when it plunged 45.47%.
• China Pharma Holdings' Current Assets stood at $6.0 million in 2022, then grew by 0.54% to $6.0 million in 2023, then plunged by 45.47% to $3.3 million in 2024, then retreated by 28.25% to $2.3 million in 2025, then slipped by 14.61% to $2.0 million in 2026.
• The last three Current Assets figures came in at $2.0 million (Q1 2026), $2.3 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.